今天3分钟我们来聊聊骨髓干细胞让阿尔茨海默病患者脑萎缩减速近一半：《自然·医学》最新临床数据

阿尔茨海默病现有药物无法逆转病情，且存在安全风险。一项IIa期临床试验显示，MSC免疫调节疗法可显著改善患者认知和日常功能，大幅减缓脑萎缩，且安全性良好。其核心是调节大脑免疫环境，为AD治疗带来新方向，但仍需III期验证。参考文献： Nature Medicine, Vol. 31, pp. 1257-1266 (2025)，Laromestrocel IIa期临床试验 ClinicalTrials.gov: NCT05233774 微信公众号「源于细胞BioInside」，《骨髓干细胞让阿尔茨海默病患者的大脑萎缩减速近一半：〈自然·医学〉最新临床数据》前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jun 10, 2026

Embed this episode

Attribution link and audio player

Ready to play

今天3分钟我们来聊聊骨髓干细胞让阿尔茨海默病患者脑萎缩减速近一半：《自然·医学》最新临床数据

0:00 4:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

峰人学院

Frequently Asked Questions

How long is this episode of 源于细胞BioInsid的个人播客?

This episode is 4 minutes long.

When was this 源于细胞BioInsid的个人播客 episode published?

This episode was published on June 10, 2026.

Can I download this 源于细胞BioInsid的个人播客 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!